Patents by Inventor Matthew Rounseville

Matthew Rounseville has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190017112
    Abstract: The present disclosure provides methods and kits for direct sequencing of nucleic acid targets. Such methods can be used to determine if one or more nucleic acid targets are present in a sample.
    Type: Application
    Filed: February 10, 2017
    Publication date: January 17, 2019
    Applicant: HTG Molecular Diagnostics, Inc.
    Inventors: Debrah Thompson, Matthew Rounseville
  • Publication number: 20080268451
    Abstract: The present invention relates to compositions, apparatus and methods useful for concurrently performing singular, multiple, high throughput, biological or chemical assays, using nuclease protection molecules which specifically bind to a target of interest. The nuclease protection molecules are capable of detecting targets in complex biological samples, including, preserved, fixed, dried, and/or cross-linked specimen. The reagents and methods of the instant invention provide an effective means for analyzing a target of interest from a complex biological sample without solubilizing or disrupting the sample. Utilization of such methods in clinical and/or diagnostic applications is also described.
    Type: Application
    Filed: March 28, 2008
    Publication date: October 30, 2008
    Inventors: Bruce SELIGMANN, Ralph Martel, Matthew Rounseville, Ihab Botros